A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Genesis Orthopedics and Sports Medicine Delivering Elite Level Sports Medicine and Orthopedic Care to the Most Underserved Part of the Community

Genesis Orthopedics and Sports Medicine, (one of the fastest-growing privately held companies in the country is serving one of the most underserved segments in sports medicine and orthopedics) which was recently named to the Inc. 5000 Fastest-Growing Privately Held Companies, is delivering the same quality of service that pro athletes receive to those who can’t afford it through its proprietary care delivery model.

Genesis Orthopedics and Sports Medicine is led by Dr. Hythem Shadid, one of the top names in Sports Medicine and Orthopedics and former Team Physician for U.S. National Soccer Teams.  Dr. Shadid and Genesis serve patients in eight locations across Chicagoland.

Genesis Orthopedics and Sports Medicine has established a new model where all people are valued and treated, regardless of economic status, with ethical pricing, and where surgery is seen as a last resort and not a preferred revenue source.

Reimbursement rates are low for Medicaid and Medicare in Illinois –  only 1 percent of orthopedic practices accept patients who are on Medicaid or Medicare. Conversely, Genesis’ patient base is made up of approximately 75 percent Medicaid and Medicare patients. “With our care delivery model, we’ve managed to do it sustainably, while still organically growing each year with new offices across Chicagoland to serve even more effectively,” said Andrew Shadid, CEO of Genesis Orthopedics & Sports Medicine.

Dr. Hythem Shadid, President and Orthopedic Surgeon at Genesis Orthopedics & Sports Medicine, is a board-certified orthopedic surgeon with the American Board of Orthopedic Surgeons and has been in practice since 1994. He is a distinguished researcher and specializes in advanced knee, hip, and shoulder conditions. He previously served as the team orthopedic physician for the men’s and women’s U.S. national soccer teams.

“Equity in healthcare is extremely important to us, so we’re dedicated to ensuring that our practice is welcoming to everyone, regardless of income, wealth, or insurance status. Everyone is welcome at Genesis, and we’re excited for what the future holds as we press forward into new possibilities for serving those in orthopedic need,” said Dr. Shadid.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy